Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00068094 · ClinicalTrials.gov registry record · Phase 1
The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics
A Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Terminated
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00068094 is a Phase 1 study that was terminated before completion, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 30 participants.
The verdict
NCT00068094, a Phase 1 study, was terminated before completion, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether probiotics, bacteria that may improve liver health, can effectively treat a chronic condition in diabetics that increases fat in the liver.
Interventions
- DRUG Probiotic-containing powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-07 |
| Est. Completion | 2006-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00068094
The ClinicalTrials.gov registry entry for NCT00068094 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Probiotic-containing powder is the first listed.
NCT00068094 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00068094 about?
NCT00068094 is a clinical study titled "The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics". The purpose of this study is to determine whether probiotics, bacteria that may improve liver health, can effectively treat a chronic condition in diabetics that increases fat in the liver.
What is the current status of trial NCT00068094?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2005-07. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00068094?
The interventions under investigation include: Probiotic-containing powder (DRUG).
Who is sponsoring clinical trial NCT00068094?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.